Intellia Therapeutics, Inc. ( NASDAQ:NTLA – Get Free Report )’s share price passed above its 50-day moving average during trading on Wednesday after an insider bought additional shares in the company. The stock has a 50-day moving average of $12.17 and traded as high as $12.53. Intellia Therapeutics shares last traded at $12.31, with a volume of 3,170,415 shares changing hands.
Analyst Ratings Changes
A number of research firms have recently commented on NTLA. HC Wainwright restated a “buy” rating and set a $25.00 price objective on shares of Intellia Therapeutics in a report on Wednesday, September 9th. Citigroup reiterated a “market outperform” rating on shares of Intellia Therapeutics in a report on Tuesday, August 25th. Wall Street Zen cut Intellia Therapeutics from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 8th. Wedbush upped their target price on Intellia Therapeutics from $12.00 to $13.00 and gave the stock a “neutral” rating in a research report on Wednesday, September 9th. Finally, Wolfe Research lowered Intellia Therapeutics from a “peer perform” rating to an “underperform” rating and set a $9.00 target price for the company. in a res...